Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Study of IDEC-Y2B8 (Zevalin) for Post Transplant Relapses of B-Cell Non-Hodgkin's Lymphoma

NCT00031642 is registered in ClinicalTrials.gov with University of Nebraska as lead sponsor.

NCT NCT00031642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00031642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Study of IDEC-Y2B8 (Zevalin) for Post Transplant Relapses of B-Cell Non-Hodgkin's Lymphoma
Lead sponsor
University of Nebraska
Phase
Phase 1/2
Overall status
Completed
Start date
January 1, 2002
Completion date
March 1, 2008
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma